<?xml version="1.0" encoding="UTF-8"?>

<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom">

  <channel>

    <title><![CDATA[openPR - Aktuelle Pressemitteilungen: Arakis Ltd]]></title>
    <description><![CDATA[openPR.de – Pressemitteilungen kostenlos einstellen]]></description>
    <lastBuildDate>Sun, 07 Jun 2026 08:43:38 +0200</lastBuildDate>
    <link>https://www.openpr.de/</link>

    <atom:link href="https://www.openpr.de/rss/" rel="self" type="application/rss+xml" />


    <item>
        <guid isPermaLink="false">pm-54476</guid>
        <pubDate>Tue, 19 Jul 2005 09:28:33 +0200</pubDate>
        <title><![CDATA[direct/Arakis Ltd: Sosei to acquire Arakis]]></title>
        <description><![CDATA[ Sosei to acquire Arakis for £106.5 million  
 
Combination with Arakis Creates Global Biopharmaceutical Company 
 
London / Tokyo, 19 July 2005: Sosei Co. Ltd ("Sosei" - 4565, Tokyo Stock Exchange MOTHERS index), a leading Japanese biopharmaceutical company with operations in Japan and the UK, announces that it has agreed terms with Arakis and its shareholders to combine its business with Arakis Limited ("Arakis"), a private UK-based biopharmaceutical company, bringing together two highly successful product discovery …]]></description>

    
    
        
    
        <link>https://www.openpr.de/news/54476/direct-Arakis-Ltd-Sosei-to-acquire-Arakis.html</link>
        <author><![CDATA[Arakis Ltd]]></author>

    </item>


  </channel>
</rss>
